Hygeia Healthcare Holdings Co., Limited reported that it repurchased 629,000 ordinary shares on 28 May 2026 via on-market transactions on the Hong Kong Stock Exchange. The buyback equates to 0.10% of the company’s outstanding shares (excluding treasury shares) prior to the transaction. Purchase prices ranged between HKD 9.46 and HKD 9.66, bringing the total consideration to HKD 6.00 million and implying an average price of approximately HKD 9.54 per share.

Post-repurchase, the company’s treasury share balance increased from 7.23 million to 7.86 million shares, while issued shares outstanding (excluding treasury stock) declined to 610.64 million. Total issued share capital remained unchanged at 618.50 million shares, as the repurchased shares are being held in treasury.

The repurchase was executed under the authority granted by shareholders on 27 June 2025, which permits the buyback of up to 61.85 million shares. Cumulative purchases under this mandate now total 7.86 million shares, representing 1.27% of the issued share base on the mandate date, leaving a remaining capacity of roughly 53.99 million shares.

In accordance with Hong Kong listing rules, Hygeia Healthcare is subject to a moratorium on issuing new shares or disposing of treasury shares until 27 June 2026.